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118 Poster Session-IIIL-2. IL-2-expanded CB NK cells formed increased immune syn-
apses with K562 tumor cells (mean 65%; 60–71%) and primary hu-
man AML blasts (mean 48%, range 39–55%), comparable to the
levels generated with peripheral blood NK cells. Additionally, we
demonstrated that ex vivo expanded CB NK cells could efficiently
kill human AML engrafted in a NOD/scid/IL-2Rg-null mouse
model. A mean 50% (37–66%) reduction in AML blasts was
observed in comparison to control groups (mean 3%;range 2.4–
4.7%) by 6 weeks post NK infusion (p\0.05). Our results suggest
that ex vivo expansion of CB NK cells is a feasible and effective
strategy for the treatment of AML.328
CHARACTERIZATION OF CTL CLONES ISOLATED FROM BONE MARROW
TRANSPLANT RECIPIENT WITH HLA-CW-MISMATCHED DONOR
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HLA-Cw disparity in a donor increases the risk of severe acute
GVHD after BMT. However, HLA-Cw-specific cytotoxic T lym-
phocytes (CTLs) generated in post-transplant recipients who de-
velop acute GVHD have not been characterized in detail. Here,
we characterized CTL clones isolated from a recipient at the on-
set of grade II acute GVHD who was transplanted from an HLA-
A, B and DRB1-matched, Cw-mismatched (recipient, Cw*0303/
Cw*0702; donor, Cw*0801/Cw*0702) unrelated donor. Seven
CTLs were isolated. Four CTLs were CD8-positive, one was
CD4-positive, and two were CD4/CD8-double positive. Three
of those including a CD8-positive CTL, a CD4-positive CTL
and a CD4/CD8-double positive CTL had exactly the same nu-
cleotide sequences in the CDR3 region of their T cell receptors,
suggesting these three CTLs with variable phenotypes originated
from a single clone. All CTLs lysed Epstein Barr virus-trans-
formed lymphoblastoid cell (B-LCL) from the recipient and donor
B-LCL transfected with the HLA-Cw*0303 cDNA construct, but
failed to lyse B-LCL from the donor. COS cells transfected with
HLA-Cw*0303 cDNA construct stimulated IFNg production by
all CTLs. Thus, all isolated CTLs recognized HLA-Cw*0303
molecule as an alloantigen. COS cells transfected with Cw*0303
mutants in which amino acids constituting peptide-binding
pockets (aa position: 114, 116, 152, or 163) were substituted
with Cw*0801-amino acids could not stimulate IFNg production
by any CTLs, whereas COS cells transfected with Cw*0303 mu-
tants bearing Cw*0801-amino acids outside the positions consti-
tuting peptide-binding pockets stimulated all CTLs as well as
the wild-type Cw*0303 construct. These data indicated that pep-
tides bound to Cw*0303 molecules influence the allorecognition
of Cw*0303-specific CTLs. Taken together, our findings suggest,
although the immunogenicity of HLA-Cw antigens is considered
to be low as a consequence of their low level of cell surface ex-
pression, HLA-Cw-specific CTL clones with a variable phenotype
can naturally arise in post-transplant recipients and cause acute
GVHD through recognition of the peptides bound to Cw mole-
cules. This is consistent with a recent statistical study showing
a significant association between some specific amino acid substi-
tutions at positions constituting peptide-binding pockets of the
HLA-Cw molecule and the occurrence of severe acute GVHD
after unrelated BMT.329
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NF-KB is a family of transcription factors with an important role
in immune and inflammatory responses, and represents a target for
the treatment of immune diseases. NF-KB inducing kinase (NIK) is
required for the activation of the NF-KB noncanonical (or alterna-
tive) pathway. We have studied the role of NIK in graft versus hostdisease (GVHD) in humans and in a murine model of GVHD.
Human T lymphocytes activated in vitro (CD3 1 CD28 anti-
bodies, and/or TNF-a) showed an initial downregulation of
NIK, followed by an increase above basal levels, during the first
48 hours. On the other hand, circulating T lymphocytes from pa-
tients with acute GVHD (aGVHD) expressed NIK while T cells
from healthy donors did not, and T lymphocytes infiltrating the
dermis of pathological lesions of those patients expressed high level
of NIK. We next explored the effects of suppressing NIK in a mu-
rine model of GVHD in mice: H2Db T lymphocytes transplanted
into fully mismatched H2Dd recipients. Donor mice were either
aly/aly (NIK deficient) or C57BL/6 (control), and recipient mice
were Balb/c. Mice recipient of BL6 cells developed a severe form
of aGVHD and died in the third week after transplant. On the con-
trary, mice transplanted with aly T lymphocytes survived for 3
months and did not develop GVHD Histopathological analysis of
skin, gut and liver of these surviving mice showed no sign of
GVHD. We next studied the fate of the infused T lymphocytes
in the early days postransplant, in order to ascertain the cause of
the difference in GVHD survival. We found that aly and BL6 T
lymphocytes had the same capacity for homing into the spleens,
but the clonal expansion of aly T lymphocytes was significantly im-
paired at day 5. Analysis of in vivo T cell divisions showed the same
kinetics for aly and BL6 T lymphocytes at 1, 3 and 5 days after
transplant. Therefore, aly T cells divided in vivo but the process
was not productive. Finally, the proportions of apoptotic aly T lym-
phocytes were higher than those of BL6, at days 1 and 3, but not at
day 5. We also detected lower amounts of Th1 cytokines levels in
the serum of mice receiving aly vs. BL6 T cells, 5 days after trans-
plant. In summary, NIK-deficient T lymphocytes had a normal
proliferative capacity but an increased apoptotic rate early after
transplant compared to controls, and were unable of mounting
a successful GVH reaction in the fully mismatched allogeneic
setting.330
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Background:Understanding the biologic milieu associated with
differing symptom profiles in allogeneic HSCT survivors with
cGVHD has the potential to clarify the pathogenesis of cGVHD
activity and tissue damage, and may direct the development of
new strategies to ameliorate symptoms and improve quality of
life.
Objective: To determine if differing cGVHD symptom profiles
are associated with unique patterns of pro-inflammatory cytokine ex-
pression and markers of systemic immune activation.
Methods: Plasma levels of sBAFF, IL-1b, IL-1 receptor antago-
nist, IL-6, soluble IL-6 receptor, soluble TNF-receptor II, MCP-
1, and MIG were assayed by sandwich ELISA. Lymphocyte subset
quantities were measured. Concurrently, the Lee Chronic GVHD
Symptom Scale, a self-report measure of cGVHD symptoms, and
clinical data were obtained. Data from 79 patients were analyzed us-
ing descriptive statistics, latent profile analysis, and multinomial lo-
gistic regression.
Results: Three distinct symptom subgroups were identified
through latent profile analysis: Group 1 (low on all symptoms),
Group 2 (prominent oral, upper GI, and weight loss symptoms);
and Group 3 (eye, muscle/joint, fatigue and mood symptoms). Mul-
tinomial logistic regression, controlling for age, length of time since
transplant, cGVHD severity, intensity of immunosuppression and
post-transplant lymphocyte reconstitution, revealed that IL-6,
TNF-RII, MCP-1 and sBAFF levels significantly distinguished the
three symptom subgroups.
